Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270763 · ClinicalTrials.gov registry record
Gene x Behavior Interaction in the Look AHEAD Study
A clinical trial of Obesity and Type 2 Diabetes, sponsored by The Miriam Hospital.
- Completed
- Registry status
- 4,108
- Enrollment target
- 1
- Study location
NCT01270763: Completed study of Obesity and Type 2 Diabetes, sponsored by The Miriam Hospital.
NCT01270763 is a study of Obesity and Type 2 Diabetes that has completed, run by The Miriam Hospital. The registered enrollment target is 4,108 participants, above the 815-participant average among 1,053 other Obesity trials with a reported enrollment target (404% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01270763, a study of Obesity and Type 2 Diabetes, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- 4,108 participants
- Enrollment target
- 1
- Study location
Study Summary
The interplay of genetic and behavioral factors is critical to understanding obesity. Behavioral weight loss intervention has emerged as a key strategy in combating obesity. However, individuals differ in their degree of success in these programs and genetic factors are known to play a role. In this application, the investigators propose to identify specific genes that predict individual differences in weight loss and high density lipoprotein cholesterol in response to behavioral intervention to help identify individuals that struggle with weight loss and cholesterol despite behavioral efforts.
Conditions Studied
Interventions
- BEHAVIORAL Intensive lifestyle intervention
- BEHAVIORAL Diabetes support and education
Study Locations (1)
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,108 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-03 |
What the finished NCT01270763 record still lists
NCT01270763 is an observational study that tracks outcomes without assigning an intervention. Its 4,108 participants enrollment target places it among the larger protocols in the corpus, above the 815-participant average among 1,053 other Obesity trials with a reported enrollment target (404% higher).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Intensive lifestyle intervention is the first listed.
NCT01270763 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01270763 about?
NCT01270763 is a clinical study titled "Gene x Behavior Interaction in the Look AHEAD Study". The interplay of genetic and behavioral factors is critical to understanding obesity. Behavioral weight loss intervention has emerged as a key strategy in combating obesity. However, individuals differ in their degree of success in these programs and genetic factors are known to play a role. In this...
What is the current status of trial NCT01270763?
This trial is currently completed. The enrollment target is 4,108 participants. The study started on 2009-07. Estimated completion is 2015-03.
What conditions does trial NCT01270763 study?
This clinical trial studies the following conditions: Obesity, Type 2 Diabetes.
What interventions are being tested in trial NCT01270763?
The interventions under investigation include: Intensive lifestyle intervention (BEHAVIORAL), Diabetes support and education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01270763?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01270763 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01270763's enrollment target sits among peer trials
4,108 24th of 1053 higher than 1,030 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia